PHIO RXi Pharmaceuticals: Expected Profit

Brandmark of Phio Pharmaceuticals Corp (PHIO)

Phio Pharmaceuticals (PHIO) is developing an immuno-oncology environment based on RNA interference, creating exclusive treatment protocols. The current valuation of future earnings illustrates the business's adaptability to costs, where 0.02 reflects the latest metric value. Fundamental gene-silencing patents ensure a high barrier to entry for third-party players, while the implementation of laboratory robotics automates predictive data analysis.

PHIO - RXi Pharmaceuticals Expected Net Income over the range 07/04/2022 - 03/31/2025

Phio Pharmaceuticals Corp - analytical breakdowns and key metrics (PHIO)

- share price and consensus valuation forecast:
Basic company analysis:PHIO, Phio Pharmaceuticals Corp
Finished products of Phio Pharmaceuticals Corp.

When assessing the resilience of Phio Pharmaceuticals (PHIO) to market downturns, it is critical to consider the absence of current revenue. Business stability is underpinned by a unique RNA interference platform designed to combat tumors. The extrapolation of future profits here reflects the daily market consensus regarding upcoming financial results, smoothing the gaps between reports. This metric measures investor expectations, transforming static balance sheet data into a dynamic forecast. High indicator values may signal an overvaluation of the asset.

Competitor analysis for Phio Pharmaceuticals

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|PRME: Projected Future Earnings|Taysha - Expected Net Income|Expected Profit uniQure NV|Net Profit Forecast MGTX (MeiraGTx PLC)|Future Profit RGNX (regenxbio.com)|Solid Biosciences Inc. - Net Profit Forecast|Expected Profit Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Expected Net Profit|BNTC - Expected Profit|Design Pharma - Future Net Profit|RCKT (Rocket Pharmaceuticals Inc) - Future Profit|4D Molecular Therapeutics (FDMT) - Projected Future Earnings|Expected Profit Lexeo Therapeutics, Inc.|Expected Net Profit Korro Bio, Inc. KRRO|Projected Future Earnings EDIT|Company Profit Forecast Silence Therapeutics Corp|Expected Profit proqr.com PRQR|CDXS - Future Profit|SGMO - Expected Profit|Projected Net Profit Nautilus Biotechnology, Inc. (NAUT)|MGX: Projected Future Earnings|Net Profit Forecast DTIL|GBIO (Generation Bio) - Projected Future Earnings|Net Profit Forecast BOLD (boundlessbio.com)|Future Profit XCUR (exicuretx.com)|Celsion Corporation - Net Profit Forecast|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings